TrialPanorama/TrialPanorama-database huggingface dataset:
Study 15323064 — Surrogate Endpoint (SUR): Blood pressure
Study 31220105 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 23924918 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23924918 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 11834105 — Predictive Biomarker (PRD): LAT mRNA
Genes: LAT
Study 9000189 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 15126525 — Surrogate Endpoint (SUR): Bone mineral density
Study 24886272 — Surrogate Endpoint (SUR): Blood pressure
Study 24886272 — Surrogate Endpoint (SUR): Serum potassium
Study 18555911 — Surrogate Endpoint (SUR): Blood pressure
Study 18555911 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 16229368 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 12201326 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 12201326 — Predictive Biomarker (PRD): SERPINA6 mRNA
Genes: SERPINA6; CBG
Study 12201326 — Surrogate Endpoint (SUR): Serum testosterone
Study 28323503 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 8392581 — Safety Biomarker (SAF): Hydroxyphenylpyruvate dioxygenase
Genes: HPD; PPD
Study 18482661 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9120459 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 8409313 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 8409313 — Surrogate Endpoint (SUR): Blood pressure
Study 15955465 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8558225 — Surrogate Endpoint (SUR): Bone mineral density
Study 1910798 — Surrogate Endpoint (SUR): Blood pressure
Study 15821899 — Surrogate Endpoint (SUR): Bone mineral density
Study 11817528 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study 11817528 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 1359139 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 24206578 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study 24206578 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study 24206578 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 24206578 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 24206578 — Pharmacodynamic Biomarker (PDY): Human leukocyte antigen DR
Study 22723577 — Surrogate Endpoint (SUR): Blood pressure
Study 10392325 — Surrogate Endpoint (SUR): Blood pressure
Study 22592508 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 8538922 — Surrogate Endpoint (SUR): Blood pressure
Study 8538922 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 30734207 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 30734207 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 30734207 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16980070 — Surrogate Endpoint (SUR): Serum creatinine
Study 1469671 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 16953055 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 12960786 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12960786 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 27631136 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study 22408775 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 17983942 — Surrogate Endpoint (SUR): Bone mineral density
Study 1673134 — Surrogate Endpoint (SUR): Blood pressure
Study 37852 — Surrogate Endpoint (SUR): Blood pressure
Study 31866099 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31621667 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 25992523 — Predictive Biomarker (PRD): F7 mRNA
Genes: F7
Study 25992523 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 2149704 — Predictive Biomarker (PRD): CPA1 mRNA
Genes: CPA1; CPA
Study 1423182 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 27859599 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 27859599 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 17332789 — Surrogate Endpoint (SUR): Blood pressure
Study 17332789 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15220949 — Surrogate Endpoint (SUR): Blood pressure
Study 15220949 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 11205182 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 24669829 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 22104540 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 2401707 — Surrogate Endpoint (SUR): Blood pressure
Study 25539418 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 12663596 — Surrogate Endpoint (SUR): Blood pressure
Study 6192514 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 18436318 — Surrogate Endpoint (SUR): Blood pressure
Study 12529345 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 1423177 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 6431470 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 15627809 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study 10491676 — Surrogate Endpoint (SUR): Blood pressure
Study 29735963 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29735963 — Surrogate Endpoint (SUR): Blood pressure
Study 25043647 — Surrogate Endpoint (SUR): Blood pressure
Study 18485457 — Surrogate Endpoint (SUR): Blood pressure
Study 8610383 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29765213 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 20228999 — Surrogate Endpoint (SUR): Blood pressure
Study 31141288 — Surrogate Endpoint (SUR): Blood pressure
Study 12429535 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 12429535 — Safety Biomarker (SAF): Hypoxanthine-guanine phosphoribosyltransferase
Genes: HPRT1; HPRT
Study 12429535 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 9449399 — Surrogate Endpoint (SUR): Blood pressure
Study 2121507 — Surrogate Endpoint (SUR): Blood pressure
Study 9471423 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 25147326 — Surrogate Endpoint (SUR): Blood pressure
Study 23418103 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 23418103 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23418103 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 11796077 — Surrogate Endpoint (SUR): Blood pressure
Study 31218842 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31218842 — Surrogate Endpoint (SUR): Pathological complete response
Study 23124538 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22592572 — Safety Biomarker (SAF): Reactive oxygen species
Study 26280577 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20658529 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study 20658529 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 20658529 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 20658529 — Predictive Biomarker (PRD): CCRL2 mRNA
Genes: CCRL2; CCR11; CCR6; CKRX; CRAM; HCR
Study 20658529 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study 20658529 — Predictive Biomarker (PRD): CD207 mRNA
Genes: CD207; CLEC4K
Study 18345708 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 10847236 — Safety Biomarker (SAF): MTHFR
Study 10847236 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 3535017 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study 27809848 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 30473179 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30473179 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19709327 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 19709327 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 17490981 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 12377799 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 12377799 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 10199429 — Predictive Biomarker (PRD): ERAL1 mRNA
Genes: ERAL1; HERA
Study 30303664 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30303664 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 25566706 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23418000 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 11819728 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study 2959236 — Surrogate Endpoint (SUR): Blood pressure
Study 29866645 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27501153 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 27501153 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 27501153 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 17483103 — Surrogate Endpoint (SUR): Blood pressure
Study 16841666 — Predictive Biomarker (PRD): MCAT mRNA
Genes: MCAT; MT
Study 10493671 — Predictive Biomarker (PRD): DMA mRNA
Genes: DMA; HLA-DMA; hCG_2001572
Study 10493671 — Predictive Biomarker (PRD): HLA-DMB mRNA
Genes: HLA-DMB; DMB; RING7
Study 15973062 — Safety Biomarker (SAF): DRD2
Study 12595862 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 8701398 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 8701398 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 25006719 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 25006719 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 25006719 — Safety Biomarker (SAF): Th2 cell
Study 15471837 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 9263614 — Surrogate Endpoint (SUR): Bone mineral density
Study 30644785 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30644785 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9835498 — Surrogate Endpoint (SUR): Serum creatinine
Study 21684281 — Predictive Biomarker (PRD): TPH1 mRNA
Genes: TPH1; TPH; TPRH; TRPH
Study 28399902 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 28399902 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 28399902 — Predictive Biomarker (PRD): Hormone receptor
Study 10688394 — Surrogate Endpoint (SUR): Blood pressure
Study 15545047 — Surrogate Endpoint (SUR): Blood pressure
Study 15545047 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15545047 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 21968126 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21968126 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18721079 — Predictive Biomarker (PRD): PPA1 mRNA
Genes: PPA1; IOPPP; PP
Study 25893955 — Surrogate Endpoint (SUR): Blood pressure
Study 21563505 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25041791 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 19474141 — Surrogate Endpoint (SUR): Bone mineral density
Study 29850873 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24492839 — Predictive Biomarker (PRD): COX4I1 mRNA
Genes: COX4I1; COX4
Study 24492839 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study 24492839 — Predictive Biomarker (PRD): MAPK1 mRNA
Genes: MAPK1; ERK2; PRKM1; PRKM2
Study 24492839 — Safety Biomarker (SAF): Cytochrome c
Study 20533969 — Surrogate Endpoint (SUR): Blood pressure
Study 12853535 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 27660650 — Predictive Biomarker (PRD): KY mRNA
Genes: KY
Study 17537770 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study 17537770 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 9443925 — Surrogate Endpoint (SUR): Bone mineral density
Study 31821071 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 31821071 — Predictive Biomarker (PRD): Hormone receptor
Study 30244144 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 26443829 — Surrogate Endpoint (SUR): Blood pressure
Study 26686359 — Surrogate Endpoint (SUR): Bone mineral density
Study 25262636 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 22549092 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 20569714 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 20569714 — Surrogate Endpoint (SUR): Blood pressure
Study 12471316 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30439452 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25772806 — Surrogate Endpoint (SUR): Bone mineral density
Study 23527358 — Predictive Biomarker (PRD): CPB1 mRNA
Genes: CPB1; CPB; PCPB
Study 11463596 — Predictive Biomarker (PRD): SIGLEC1 mRNA
Genes: SIGLEC1; SN
Study 30019653 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 20102855 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 14872148 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25851895 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 25851895 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 25851895 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 12584036 — Surrogate Endpoint (SUR): Bone mineral density
Study 9086359 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 30795753 — Surrogate Endpoint (SUR): Blood pressure
Study 30795753 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18325918 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 23548570 — Surrogate Endpoint (SUR): Serum calcium
Study 18826865 — Surrogate Endpoint (SUR): Blood pressure
Study 17396041 — Surrogate Endpoint (SUR): Serum creatinine
Study 15711571 — Predictive Biomarker (PRD): CR1 mRNA
Genes: CR1; C3BR
Study 31256870 — Surrogate Endpoint (SUR): Serum creatinine
Study 25138265 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 25138265 — Safety Biomarker (SAF): BDNF
Study 3534901 — Safety Biomarker (SAF): Biliary glycoprotein 1
Genes: CEACAM1; BGP; BGP1
Study 30895460 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30895460 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 28696415 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAC mRNA
Genes: STAC; STAC1
Study 28696415 — Predictive Biomarker (PRD): ZNF385D mRNA
Genes: ZNF385D; ZNF659
Study 28696415 — Predictive Biomarker (PRD): NCAM1 mRNA
Genes: NCAM1; NCAM
Study 28696415 — Predictive Biomarker (PRD): KMT2E mRNA
Genes: KMT2E; MLL5
Study 23212150 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 23212150 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 12656658 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study 3946946 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study 29878870 — Predictive Biomarker (PRD): SIT1 mRNA
Genes: SIT1; SIT
Study 22797673 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21129229 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 21215382 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 21215382 — Surrogate Endpoint (SUR): Blood pressure
Study 18661524 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study 12439651 — Surrogate Endpoint (SUR): Blood pressure
Study 28229374 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 28229374 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 28229374 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 28229374 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 28229374 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 20024739 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 17901665 — Surrogate Endpoint (SUR): Serum calcium
Study 17901665 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 18800454 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18800454 — Surrogate Endpoint (SUR): Blood pressure
Study 29380563 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 22108921 — Safety Biomarker (SAF): Complement factor D
Genes: CFD; DF; PFD
Study 2660750 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study 27664274 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 24577383 — Surrogate Endpoint (SUR): Blood pressure
Study 9825367 — Safety Biomarker (SAF): RFC1
Genes: A1; PO-GA; RFC140; MHCBFB
Study 2562233 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 2562233 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 29538243 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 27513406 — Surrogate Endpoint (SUR): Forced vital capacity
Study 23701571 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22868522 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20602006 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 20602006 — Surrogate Endpoint (SUR): Blood pressure
Study 12819247 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 30175792 — Predictive Biomarker (PRD): XG mRNA
Genes: XG; PBDX
Study 25037750 — Predictive Biomarker (PRD): LHX2 mRNA
Genes: LHX2; LH2
Study 16048137 — Surrogate Endpoint (SUR): Serum calcium
Study 8534781 — Surrogate Endpoint (SUR): Serum sodium
Study 8534781 — Surrogate Endpoint (SUR): Serum creatinine
Study 31580931 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30149898 — Predictive Biomarker (PRD): WAP four-disulfide core domain protein 2
Genes: WFDC2; HE4; WAP5
Study 30149898 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 26123137 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 26123137 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study 24971988 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 26932132 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 7877544 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30171497 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study 30171497 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 25486372 — Predictive Biomarker (PRD): CGAS mRNA
Genes: CGAS; C6orf150; MB21D1
Study 23759749 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23759749 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 23759749 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 16883907 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 16883907 — Surrogate Endpoint (SUR): Serum creatinine
Study 16883907 — Surrogate Endpoint (SUR): Blood pressure
Study 22170364 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8950879 — Surrogate Endpoint (SUR): Bone mineral density
Study 8950879 — Surrogate Endpoint (SUR): New morphometric vertebral fractures
Study 6783861 — Surrogate Endpoint (SUR): Blood pressure
Study 2476624 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 26114854 — Surrogate Endpoint (SUR): Blood pressure
Study 16702369 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 11742880 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11742880 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15342298 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15342298 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 22006202 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22006202 — Surrogate Endpoint (SUR): Serum creatinine
Study 18049022 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18049022 — Surrogate Endpoint (SUR): Blood pressure
Study 18049022 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 11004845 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11004845 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 11004845 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 11004845 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 11004845 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 1618361 — Surrogate Endpoint (SUR): Blood pressure
Study 15964386 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 30506227 — Predictive Biomarker (PRD): NOVA2 mRNA
Genes: NOVA2; ANOVA; NOVA3
Study 18324566 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1